NDC 33342-209 – Pramipexole Dihydrochloride
Pramipexole Dihydrochloride .75 mg/1 · Tablet, Extended Release · Oral
Product NDC33342-209
Product details
- Brand name
- Pramipexole Dihydrochloride
- Generic name
- Pramipexole Dihydrochloride
- Labeler
- Macleods Pharmaceuticals Limited
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA206156
- Marketed since
- August 24, 2020
- Listing expires
- December 31, 2026
- Pharmacologic class
- Nonergot Dopamine Agonist
Active ingredients
- Pramipexole Dihydrochloride .75 mg/1
Uses, dosage, side effects and warnings for pramipexole dihydrochloride →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 33342-209-07 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-209-07) | Aug 24, 2020 |
| 33342-209-12 | 10 BLISTER PACK in 1 CARTON (33342-209-12) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | Aug 24, 2020 |
Other pramipexole dihydrochloride products
- 50090-7816 Pramipexole Dihydrochloride 1.5 mg/1 · Tablet · A-S Medication Solutions
- 50090-2455 Pramipexole Dihydrochloride .5 mg/1 · Tablet · A-S Medication Solutions
- 50090-3280 Pramipexole Dihydrochloride .25 mg/1 · Tablet · A-S Medication Solutions
- 50090-5036 Pramipexole Dihydrochloride 1.5 mg/1 · Tablet · A-S Medication Solutions
- 62332-003 Pramipexole Dihydrochloride .125 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-155 Pramipexole Dihydrochloride .75 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.
- 62332-005 Pramipexole Dihydrochloride .5 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-007 Pramipexole Dihydrochloride 1.5 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-006 Pramipexole Dihydrochloride 1 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-156 Pramipexole Dihydrochloride 1.5 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.
- 62332-004 Pramipexole Dihydrochloride .25 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-154 Pramipexole Dihydrochloride .375 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.